Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Pet Diabetes Care Market Size & Growth Forecast 2026–2035, By Segments (Distribution Channel, Animal Type, Solution), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11285| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Pet Diabetes Care Market size was assessed at USD 2.24 Billion in 2025 and is poised to grow at a 9% CAGR between 2026 and 2035, exceeding USD 5.3 Billion by 2035. The industry revenue for 2026 is estimated at USD 2.41 billion.

Base Year Value (2025)
USD 2.24 Billion
CAGR (2026-2035)
9%
Forecast Year Value (2035)
USD 5.3 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Pet Diabetes Care Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 42.40% share due to high pet ownership, strong disease awareness, established veterinary care systems, and consistent use of insulin therapy and glucose monitoring solutions.
  • Asia Pacific is growing at 10.17% CAGR, supported by rising pet adoption, improving veterinary access, and increasing structured diagnosis and long-term management of pet diabetes conditions.

Segment Momentum

  • Veterinary hospitals and clinics lead with 43.46% share in 2025 due to their central role in diagnosis, insulin initiation, and ongoing treatment supervision requiring professional veterinary oversight.
  • Cats are the fastest-growing segment as improving veterinary awareness and owner willingness to manage feline metabolic conditions increases adoption of diagnostics, monitoring, and long-term diabetes care.

Market Expansion Drivers

  • Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand.
  • Growing pet insurance adoption improving affordability of long-term diabetic care solutions.
  • Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Key companies in the pet diabetes care market include Zoetis Inc. (United States), Merck Animal Health (United States), Boehringer Ingelheim International GmbH (Germany), Becton, Dickinson and Company (United States), Nova Biomedical Corporation (United States), I-SENS, Inc. (South Korea), Allison Medical, Inc. (United States), Abbott Laboratories (United States), Elanco Animal Health Incorporated (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand

A larger diagnosed population of diabetic pets is directly increasing the recurring care burden in the pet diabetes care market, since disease management depends on ongoing insulin therapy, glucose monitoring, syringes, test strips, prescription diets, and repeat veterinary consultations rather than one-time treatment. As obesity, aging, and other chronic conditions become more common in companion animals, veterinarians are screening more actively and initiating earlier treatment pathways, which raises product utilization over extended periods. This dynamic is encouraging market growth by shifting demand toward continuous disease management solutions and making adherence tools, monitoring systems, and reliable supply access more central to purchasing decisions.

Growing pet insurance adoption improving affordability of long-term diabetic care solutions

Wider pet insurance coverage is reducing the out-of-pocket barrier that often delays diagnosis, limits follow-up visits, or leads owners to choose only basic management options, creating a more stable treatment pathway in the pet diabetes care market. When reimbursement supports consultations, diagnostics, insulin prescriptions, and monitoring supplies, pet owners are more likely to accept long-term care plans and maintain consistent therapy over time. That change in spending behavior is influencing market adoption of higher-value diabetes management products, particularly monitoring devices and structured care regimens that require sustained financial commitment.

Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption

A growing pet population, combined with higher willingness to spend on animal health, is widening the addressable base for advanced care tools in the pet diabetes care market. As owners increasingly treat pets as long-term family companions, they are more receptive to technologies that help manage chronic disease at home and reduce uncertainty between veterinary visits. This is increasing demand for the market by improving acceptance of glucose monitoring devices and related consumables, while veterinary clinics are also more inclined to recommend these solutions when clients show greater readiness to invest in routine monitoring and better glycemic control.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand 2.00% Moderate North America, Europe High Near Term
Growing pet insurance adoption improving affordability of long-term diabetic care solutions 1.70% Moderate North America, Asia Pacific High Mid Term
Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption 1.40% Low Asia Pacific, Latin America Emerging Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
42.40% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 42.40% share of the pet diabetes care market. This leadership is backed by high companion animal ownership, broader awareness of chronic disease management in pets, and established veterinary care pathways that enable earlier diagnosis and consistent treatment. The region’s market activity is further aided by routine glucose monitoring, sustained use of insulin therapies, and stronger access to specialized veterinary services, all of which keep treatment adherence and product demand comparatively high.

Asia Pacific is projected to expand at a 10.17% CAGR over the forecast period in the pet diabetes care market, driven by rising pet adoption and improving access to veterinary services across urban centers. Growth is accelerating as more pet owners seek formal diagnosis and long-term management for companion animal health conditions, while veterinary infrastructure and availability of diabetes-related care products continue to improve. This is translating into broader uptake of monitoring tools and treatment regimens as animal healthcare spending becomes more structured across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Veterinary Management

Germany prioritizes evidence-based veterinary diabetes care supported by advanced diagnostic practices and structured treatment protocols. German veterinary providers are integrating reliable monitoring technologies and tailored insulin therapies to strengthen chronic disease management for diabetic pets.

France 🇫🇷

Preventive Veterinary Focus

France emphasizes earlier diagnosis and structured follow-up for diabetic companion animals through established veterinary care networks. French clinics continue incorporating modern glucose monitoring technologies to improve treatment planning and long-term patient outcomes.

Italy 🇮🇹

Specialized Clinical Care

Italy is expanding access to specialized veterinary endocrinology services for companion animals requiring long-term diabetes management. Veterinary professionals in Italy are increasing the use of advanced diagnostics and individualized treatment plans to improve disease control.

Japan 🇯🇵

Aging Pet Support

Japan focuses on diabetes care solutions suited to its growing aging companion animal population. Veterinary practices in Japan are adopting minimally invasive monitoring methods and personalized treatment approaches that improve routine disease management for elderly pets.

South Korea 🇰🇷

Digital Veterinary Adoption

South Korea is strengthening pet diabetes management through connected veterinary services and growing acceptance of digital monitoring technologies. Companion animal clinics are expanding access to diagnostic tools and owner education that support more consistent diabetes care.

United States 🇺🇸

Advanced Companion Care

The U.S. market emphasizes continuous glucose monitoring, insulin management, and digital veterinary care for companion animals. Clinics across the U.S. are expanding preventive diabetes management services while pet owners increasingly seek convenient monitoring solutions that improve long-term treatment adherence.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Pet Diabetes Care Market Share (%), Distribution Channel, 2025

Veterinary Hospitals & Clinics
Retail Pharmacies
E-commerce

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Distribution Channel Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs E-commerce (Fastest-Growing Segment)

Veterinary Hospitals & Clinics held a 43.46% share of the pet diabetes care market in 2025, reflecting their central role in diagnosis, insulin initiation, glucose monitoring, and ongoing treatment adjustment. This channel maintains leadership because pet diabetes care often depends on professional supervision, especially when dosage changes, device selection, and management of complications require direct veterinary involvement. Owners also tend to rely on clinics for trusted treatment recommendations and immediate access to prescription-led care, which helps sustain the segment’s leading share.

E-commerce is emerging as the fastest-growing distribution channel in the pet diabetes care market as pet owners increasingly shift routine purchasing of consumables and long-term care supplies to digital platforms. Its growth is reinforced through the convenience of repeat ordering, broader product visibility, and easier price comparison for items needed on an ongoing basis, such as monitoring accessories and diabetes management products. Compared with traditional offline channels, e-commerce is gaining momentum because it fits the recurring nature of pet diabetes care while reducing purchase friction for owners managing continuous treatment.

Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)

Within the pet diabetes care market, dogs accounted for the largest share in 2025, reinforced through consistent diagnosis and treatment engagement through veterinary care settings. The segment’s leadership is maintained through the structured care pathway often associated with canine diabetes management, where owners are more likely to pursue regular monitoring, insulin administration, and follow-up visits over extended periods. This pattern supports steady demand for diabetes care products and services across the dog population.

Cats represent the fastest-growing animal type in the pet diabetes care market, driven by rising attention to feline metabolic health and increasing treatment adoption among cat owners. Growth is gaining pace as veterinary awareness and owner willingness to manage chronic feline conditions improve, leading to greater uptake of diagnostics, glucose monitoring, and ongoing diabetes support. Relative to dogs, the cat segment is expanding faster because it is advancing from a lower base of treatment penetration and benefiting from improving recognition of care needs.

Segment Sub-Segment Largest Segment Fastest Growing
Distribution Channel Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce Veterinary Hospitals & Clinics E-commerce
Animal Type Dogs, Cats Dogs Cats
Solution Treatment, Glucose Monitoring Devices Treatment Glucose Monitoring Devices
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the pet diabetes care market:

1. Zoetis Inc. (United States)

2. Merck Animal Health (United States)

3. Boehringer Ingelheim International GmbH (Germany)

4. Becton Dickinson and Company (United States)

5. Nova Biomedical Corporation (United States)

6. I-SENS Inc. (South Korea)

7. Allison Medical Inc. (United States)

8. Abbott Laboratories (United States)

9. Elanco Animal Health Incorporated (United States)

Rising awareness regarding chronic pet health conditions is driving innovation in the pet diabetes care market. Manufacturers are introducing advanced glucose monitoring solutions, insulin delivery systems, and specialized nutritional products tailored for companion animals. Growing expenditure on veterinary healthcare and preventive treatment solutions is also encouraging continuous expansion of diabetes management offerings in the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Boehringer Ingelheim Aug-23 The FDA authorized SENVELGO (velagliflozin), a novel oral SGLT2 inhibitor for the management of feline diabetes. By offering a convenient once-daily liquid formulation, the drug represents a significant therapeutic innovation that reduces the frequency of insulin injections, addressing a critical compliance barrier in pet care and establishing a new standard for glucose regulation in diabetic cats.
Zoetis Sep-22 Zoetis acquired NewMetrica, a UK-based developer of health-related quality-of-life assessment tools for pets. This acquisition integrates specialized digital monitoring capabilities into Zoetis’s existing pet health portfolio, enabling more precise clinical assessment and improved outcomes for chronic condition management, including diabetes care, through advanced data-driven veterinary diagnostics.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Pet Diabetes Care Market — Custom Segments

Segment Sub-Segment
No segment data available.

Pet Diabetes Care Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the pet diabetes care market?

The market valuation of the pet diabetes care is USD 2.41 billion in 2026.

How much is the pet diabetes care industry expected to grow by 2035?

Pet Diabetes Care Market size is projected to expand significantly moving from USD 2.24 billion in 2025 to USD 5.3 billion by 2035 with a CAGR of 9% during the 2026-2035 forecast period.

How is rising diabetes prevalence in companion animals impacting demand for long-term pet diabetes care?

Increasing diagnosis of diabetic and chronically ill pets is driving sustained demand for insulin, monitoring tools, and veterinary care, shifting the market toward continuous disease management and recurring product utilization over time.

What role is pet insurance playing in shaping treatment adoption in the pet diabetes care market?

Expanding pet insurance coverage is improving affordability of diagnostics, insulin, and monitoring solutions, encouraging owners to adopt structured long-term care plans and increasing acceptance of higher-value diabetes management products.

Why are veterinary hospitals and clinics the leading distribution channel?

Veterinary hospitals and clinics lead with 43.46% share in 2025 due to their central role in diagnosis, insulin initiation, and ongoing treatment supervision requiring professional veterinary oversight.

Why are cats the fastest-growing animal type in pet diabetes care?

Cats are the fastest-growing segment as improving veterinary awareness and owner willingness to manage feline metabolic conditions increases adoption of diagnostics, monitoring, and long-term diabetes care.

Why is North America the leading region in pet diabetes care?

North America holds 42.40% share due to high pet ownership, strong disease awareness, established veterinary care systems, and consistent use of insulin therapy and glucose monitoring solutions.

What is driving Asia Pacific growth in pet diabetes care?

Asia Pacific is growing at 10.17% CAGR, supported by rising pet adoption, improving veterinary access, and increasing structured diagnosis and long-term management of pet diabetes conditions.

Which companies are driving growth in the pet diabetes care landscape?

Key companies in the pet diabetes care market include Zoetis Inc. (United States), Merck Animal Health (United States), Boehringer Ingelheim International GmbH (Germany), Becton, Dickinson and Company (United States), Nova Biomedical Corporation (United States), I-SENS, Inc. (South Korea), Allison Medical, Inc. (United States), Abbott Laboratories (United States), Elanco Animal Health Incorporated (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →